Differential effect of sulfonylureas on production of reactive oxygen species and apoptosis in cultured pancreatic ß-cell line, MIN6

This is not the first study to find damaging effects of the class sulfonylureas on the beta cells of the pancreas. The information has probably been known for at least 5 years now, and yet this class of drugs for diabetes is widely used. How many diabetics were informed that the drug their doctor gave them will ultimately increase the risk for them to be on insulin? I can’t say I’ve ever come across one in my office or in the community. All of this points to the overwhelming conclusion that lifestyle changes are the ONLY answer to managing this deadly condition. Every pharmaceutical approach has risks that can outweigh the benefits. This is NOT the case with lifestyle changes.

Read entire article here

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.